Xenon Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.

About XENE

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. 

CEO
Ian C. Mortimer
CEOIan C. Mortimer
Employees
370
Employees370
Headquarters
Burnaby, British Columbia
HeadquartersBurnaby, British Columbia
Founded
1996
Founded1996
Employees
370
Employees370

XENE Key Statistics

Market cap
5.55B
Market cap5.55B
Price-Earnings ratio
-13.34
Price-Earnings ratio-13.34
Dividend yield
Dividend yield
Average volume
1.41M
Average volume1.41M
High today
$59.08
High today$59.08
Low today
$56.25
Low today$56.25
Open price
$56.59
Open price$56.59
Volume
1.55M
Volume1.55M
52 Week high
$63.95
52 Week high$63.95
52 Week low
$26.74
52 Week low$26.74

Stock Snapshot

As of today, Xenon Pharmaceuticals(XENE) shares are valued at $58.02. The company's market cap stands at 5.55B, with a P/E ratio of -13.34.

As of 2026-03-31, Xenon Pharmaceuticals(XENE) stock has fluctuated between $56.25 and $59.08. The current price stands at $58.02, placing the stock +3.1% above today's low and -1.8% off the high.

The Xenon Pharmaceuticals(XENE)'s current trading volume is 1.55M, compared to an average daily volume of 1.41M.

In the last year, Xenon Pharmaceuticals(XENE) shares hit a 52-week high of $63.95 and a 52-week low of $26.74.

In the last year, Xenon Pharmaceuticals(XENE) shares hit a 52-week high of $63.95 and a 52-week low of $26.74.

XENE News

Nasdaq 4d
Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know

Key Points The chief medical officer of Xenon Pharmaceuticals directly sold 1,410 common shares for a transaction value of $78,000 on March 13, 2026. This sal...

Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know
Nasdaq 5d
Xenon Pharmaceuticals Price Target Increased by 41.64% to 80.01

The average one-year price target for Xenon Pharmaceuticals (NasdaqGM:XENE) has been revised to $80.01 / share. This is an increase of 41.64% from the prior est...

Xenon Pharmaceuticals Price Target Increased by 41.64% to 80.01

Analyst ratings

100%

of 20 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own XENE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.